Taiwan FDA registration 0c3bb40fa0863197fc0acafe9fcac0b1

"Dibi" immunopathological histochemical staining reagent and kit (unsterilized)

TW: “帝比”免疫病理組織化學染色試劑及套組(未滅菌)
Taiwan flagTaiwan·Risk Class 1·DB BIOTECH, SPOL. S R.O.·Registered Sep 13, 2012 – Sep 13, 2017Cancelled
Registration details
Analysis ID
0c3bb40fa0863197fc0acafe9fcac0b1
Customs Code
DHA04401215805
Company information
Manufacturer Country
Slovakia
Authorized Representative
LI-TZUNG BIOTECHNOLOGY,INC.
Product details
Intended Use
Limited to the first level identification range of immunopathological histochemical reagents and kits (B.1860) of the Measures for the Administration of Medical Devices.
Product Type (Level 1)
B Hematology, pathology, and genetics
Product Type (Level 2)
B.1860 Immunopathological histochemistry reagents and kits
Import Information
import
Dates and status
Registration Date
Sep 13, 2012
Expiry Date
Sep 13, 2017
Cancellation Date
Dec 13, 2019
Cancellation information
Status
Logged out
Reason
許可證已逾有效期
About this record

Access comprehensive regulatory information for "Dibi" immunopathological histochemical staining reagent and kit (unsterilized) in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 1 medical device is registered under number 0c3bb40fa0863197fc0acafe9fcac0b1 and manufactured by DB BIOTECH, SPOL. S R.O.. The authorized representative in Taiwan is LI-TZUNG BIOTECHNOLOGY,INC..

This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.

Free DatabasePowered by Pure Global AI89,000+ Devices